Shares of other companies:
May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
3M Stock: Dividend Likely Cut In Half
May 1, 2024
Amazon Q1 Review: Best Of Big Tech Bunch
April 30, 2024
Tesla: The Thesis Is Stronger Than Ever
April 30, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
SAVA Stock News and Mentions of Cassava Sciences, Inc. Stocktwits
Updated: May 2, 2024 (11:06)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Cassava Sciences Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Cassava Sciences, Inc. (SAVA).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Cassava Sciences stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Cassava Sciences, Inc. (SAVA)
May 1, 2024 (13:10) / "GlobeNewswire" (by Inc.)
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
AUSTIN, Texas, May 01, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( NASDAQ: SAVA ) ( "Cassava Sciences" or the "Company" ) has been advised by NASDAQ that end-of-day ( "EOD" ) tomorrow May 2, 2024, will be the last and final trading day for SAVAW warrants on NASDAQ. After EOD May 2, the ...
In Article Trend: Neutral
April 15, 2024 (13:20) / "GlobeNewswire" (by Inc.)
Redemption Date Announced for Warrants
AUSTIN, Texas, April 15, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( Nasdaq: SAVA ) ( "Cassava Sciences" or the "Company" ) today announced that Monday, May 6, 2024 is the last and final day to exercise the warrants that were previously distributed to its shareholders on January 3, 2024 ...
In Article Trend: Somewhat-Bullish
April 12, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
IBD Rating Upgrades: Cassava Sciences Flashes Improved Relative Price Strength
Cassava Sciences ( SAVA ) had its Relative Strength ( RS ) Rating upgraded from 69 to 76 Friday - a welcome improvement, but still shy of the 80 or higher score you look for. X IBD's proprietary rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Somewhat-Bullish
April 5, 2024 (10:00) / "Benzinga" (by Globe Newswire)
CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, April 05, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cassava Sciences, Inc.
In Article Trend: Neutral
April 2, 2024 (14:20) / "Benzinga" (by Globe Newswire)
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm - Cassava Sciences ( NASDAQ:SAVA )
LOS ANGELES, April 02, 2024 ( GLOBE NEWSWIRE ) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA for violations of §§10 ( b ) and 20 ( a ) of the Securities ...
In Article Trend: Neutral
April 1, 2024 (19:40) / "Benzinga" (by Globe Newswire)
Cassava Sciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 2, 2024 deadline. - Cassava Sciences ( NASDAQ:SAVA )
Investors can contact the law firm at no cost to learn more about recovering their losses
In Article Trend: Neutral
April 1, 2024 (14:20) / "Business Insider" (by NEWSFILE)
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California-- ( Newsfile Corp. - April 1, 2024 ) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cassava Sciences, Inc.. ( "Cassava" or "the Company" ) ( NASDAQ: SAVA ) for violations of §§10 ( b ) and 20 ( a ) ...
In Article Trend: Neutral
March 31, 2024 (19:07) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 31, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed ...
In Article Trend: Neutral
March 31, 2024 (16:13) / "Benzinga" (by Globe Newswire)
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 31, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. SAVA between August 18, 2022 and October 12, 2023, both dates inclusive ( the "Class Period" ) of the important April 2, 2024 lead ...
In Article Trend: Neutral
March 31, 2024 (08:00) / "Benzinga" (by Globe Newswire)
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 31, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA and certain of its officers.
In Article Trend: Neutral
March 29, 2024 (14:40) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hut 8 - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hut 8 PR ...
In Article Trend: Somewhat-Bullish
March 29, 2024 (14:40) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LuxUrban - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LuxUrban PR ...
In Article Trend: Neutral
March 29, 2024 (14:40) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx PR ...
In Article Trend: Neutral
March 29, 2024 (14:40) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NYCB - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NYCB PR ...
In Article Trend: Neutral
March 29, 2024 (14:40) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava PR ...
In Article Trend: Neutral
March 28, 2024 (15:01) / "Benzinga" (by Globe Newswire)
Holzer & Holzer, LLC Reminds Shareholders of April 2, 2024 Lead Plaintiff Deadline in Cassava Sciences, Inc. ( SAVA ) Class Action - Nationally Ranked Investors' Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Cassava Sciences ( NASDAQ:SAVA )
ATLANTA, March 28, 2024 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA. The lawsuit alleges Defendants made materially false and misleading statements and/or failed to disclose material adverse ...
In Article Trend: Neutral
March 28, 2024 (14:15) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 28, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA and reminds investors of the April 2, 2024 deadline to seek the role of lead plaintiff ...
In Article Trend: Neutral
March 26, 2024 (01:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , InMode ( NASDAQ:INMD )
NEW YORK, March 25, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cassava Sciences, Inc. SAVA, New York Community Bancorp, Inc.
In Article Trend: Neutral
March 25, 2024 (13:13) / "GlobeNewswire" (by Inc.)
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
AUSTIN, Texas, March 25, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( Nasdaq: SAVA ) , a biotechnology company focused on Alzheimer's disease, today announced the completion of another interim safety review of simufilam in on-going Phase 3 clinical trials in patients with Alzheimer's ...
In Article Trend: Somewhat-Bullish
March 24, 2024 (19:45) / "Benzinga" (by Globe Newswire)
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 24, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. SAVA between August 18, 2022 and October 12, 2023, both dates inclusive ( the "Class Period" ) of the important April 2, 2024 lead ...
In Article Trend: Neutral
March 24, 2024 (08:00) / "Benzinga" (by Globe Newswire)
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ( SAVA )
NEW YORK, March 24, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA and certain of its officers.
In Article Trend: Neutral
March 23, 2024 (17:54) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 23, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed ...
In Article Trend: Neutral
March 22, 2024 (01:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , InMode ( NASDAQ:INMD )
NEW YORK, March 21, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cassava Sciences, Inc. SAVA, New York Community Bancorp, Inc.
In Article Trend: Neutral
March 21, 2024 (16:30) / "Benzinga" (by Benzinga Insights)
( SAVA ) - Analyzing Cassava Sciences's Short Interest - Cassava Sciences ( NASDAQ:SAVA )
Cassava Sciences's SAVA short percent of float has fallen 3.46% since its last report. The company recently reported that it has 11.76 million shares sold short, which is 29.54% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
March 19, 2024 (14:45) / "Benzinga" (by Globe Newswire)
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 19, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA and reminds investors of the April 2, 2024 deadline to seek the role of lead plaintiff ...
In Article Trend: Neutral
March 18, 2024 (01:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , InMode ( NASDAQ:INMD )
NEW YORK, March 17, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cassava Sciences, Inc. SAVA, New York Community Bancorp, Inc.
In Article Trend: Neutral
March 17, 2024 (08:00) / "Benzinga" (by Globe Newswire)
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 17, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA and certain of its officers.
In Article Trend: Neutral
March 16, 2024 (18:00) / "Benzinga" (by Globe Newswire)
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 16, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. SAVA between August 18, 2022 and October 12, 2023, both dates inclusive ( the "Class Period" ) of the important April 2, 2024 lead ...
In Article Trend: Neutral
March 15, 2024 (19:26) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 15, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed ...
In Article Trend: Neutral
March 13, 2024 (01:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, Cassava, and Amylyx and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , Maplebear ( NASDAQ:CART )
NEW YORK, March 12, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GrafTech International Ltd. EAF, Maplebear, Inc. d/b/a Instacart CART, Cassava ...
In Article Trend: Neutral
March 12, 2024 (20:15) / "Benzinga" (by Globe Newswire)
ROSEN, A LEADING NATIONAL FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 12, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. SAVA between August 18, 2022 and October 12, 2023, both dates inclusive ( the "Class Period" ) of the important April 2, 2024 lead ...
In Article Trend: Neutral
March 12, 2024 (03:51) / "Benzinga" (by Benzinga Neuro)
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report - Cassava Sciences ( NASDAQ:SAVA )
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration ( FDA ) .
In Article Trend: Neutral
March 12, 2024 (02:33) / "Benzinga" (by Benzinga Neuro)
BA, ORCL, META, SAVA, TSLA: Why These 5 Stocks Are Trending Today - WisdomTree Industrial Metals Enhanced ( NASDAQ:META ) , Boeing ( NYSE:BA )
On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12% to 38,769.66. However, the NASDAQ and the S&P 500 indices fell by 0.41% and 0.11% respectively. Amidst this, several stocks caught the attention of retail traders and ...
In Article Trend: Neutral
March 10, 2024 (08:00) / "Benzinga" (by Globe Newswire)
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 10, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or "the Company" ) SAVA and certain of its officers.
In Article Trend: Neutral
March 9, 2024 (04:30) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, Cassava, and Amylyx and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , Maplebear ( NASDAQ:CART )
NEW YORK, March 08, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GrafTech International Ltd. EAF, Maplebear, Inc. d/b/a Instacart CART, Cassava ...
In Article Trend: Neutral
March 7, 2024 (15:45) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 07, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed ...
In Article Trend: Neutral
March 7, 2024 (15:15) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 07, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cassava Sciences, Inc. ( "Cassava" or the "Company" ) SAVA and reminds investors of the April 2, 2024 deadline to seek the role of lead plaintiff ...
In Article Trend: Neutral
March 6, 2024 (00:10) / "Benzinga" (by Globe Newswire)
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA - Cassava Sciences ( NASDAQ:SAVA )
NEW YORK, March 05, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. SAVA between August 18, 2022 and October 12, 2023, both dates inclusive ( the "Class Period" ) of the important April 2, 2024 lead ...
In Article Trend: Neutral
March 5, 2024 (02:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, Amylyx, Sunnova, and DICK'S Sporting Goods and Encourages Investors to Contact the Firm - Amylyx Pharma ( NASDAQ:AMLX ) , Dick's Sporting Goods ( NYSE:DKS )
NEW YORK, March 04, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cassava Sciences, Inc. SAVA, Amylyx Pharmaceuticals, Inc.
In Article Trend: Neutral
March 4, 2024 (14:15) / "Benzinga" (by Globe Newswire)
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference - Cassava Sciences ( NASDAQ:SAVA )
AUSTIN, Texas, March 04, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. SAVA, a clinical-stage biotechnology company focused on Alzheimer's disease, today announced plans to present a virtual oral presentation at the International Conference on Alzheimer's and Parkison's Disease ( AD/PD 2024 ) ...
In Article Trend: Neutral
March 4, 2024 (14:15) / "GlobeNewswire" (by Cassava Sciences)
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
AUSTIN, Texas, March 04, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( Nasdaq: SAVA ) , a clinical-stage biotechnology company focused on Alzheimer's disease, today announced plans to present a virtual oral presentation at the International Conference on Alzheimer's and Parkison's Disease ...
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website